Evidence map›Paper›PMID 40429396›Full record

ArticleJournal of clinical medicine2025

Neurometabolite Changes After Transcranial Photobiomodulation in Major Depressive Disorder: A Randomized Controlled Trial Investigating Dose-Dependent Effects.

David R A Coelho, Ümit Tural, Aura Maria Hurtado Puerto, Katherine Anne Collins, Maia Beth Gersten, Zamfira Parincu, Kari Siu, Dan Vlad Iosifescu, Eva-Maria Ratai, Paolo Cassano and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

David R A CoelhoDivision of Neuropsychiatry and Neuromodulation, Massachusetts General Hospital, Boston, MA 02129, USA.ORCID 0000-0003-4217-2399
Ümit TuralNathan Kline Institute for Psychiatric Research, Orangeburg, NY 10962, USA.ORCID 0000-0002-1593-2180
Aura Maria Hurtado PuertoDivision of Neuropsychiatry and Neuromodulation, Massachusetts General Hospital, Boston, MA 02129, USA.
Katherine Anne CollinsNathan Kline Institute for Psychiatric Research, Orangeburg, NY 10962, USA.ORCID 0000-0002-6717-879X
Maia Beth GerstenDivision of Neuropsychiatry and Neuromodulation, Massachusetts General Hospital, Boston, MA 02129, USA.
Zamfira ParincuDepartment of Psychiatry, New York University Grossman School of Medicine, New York, NY 10016, USA.
Kari SiuNathan Kline Institute for Psychiatric Research, Orangeburg, NY 10962, USA.ORCID 0009-0001-8161-2089
Dan Vlad IosifescuNathan Kline Institute for Psychiatric Research, Orangeburg, NY 10962, USA.
Eva-Maria RataiAthinoula A. Martinos Center for Biomedical Imaging, Charlestown, MA 02129, USA.
Paolo CassanoDivision of Neuropsychiatry and Neuromodulation, Massachusetts General Hospital, Boston, MA 02129, USA.ORCID 0000-0003-0225-199X
Akila WeerasekeraDepartment of Psychiatry, Harvard Medical School, Boston, MA 02114, USA.ORCID 0000-0003-0446-7604

Funding

US National Institute of Mental Health R61/R33 MH122647
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

dose-dependentmajor depressive disorderneurometabolitesphotobiomodulationtranscranial photobiomodulation

Identifiers

PMID40429396
PMCPMC12112509

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.